U7D-1 是一种首创的、有效的和选择性的泛素特异性蛋白酶 7(USP7)PROTAC 降解剂,在 RS4;11 细胞中 DC50 为 33 nM,具有抗癌活性,并可诱导 Jeko-1 细胞凋亡(apoptosis)(粉色:USP7 配体(MS-C74307);蓝色:Cereblon 配体(MS-N78428);黑色:连接子)。
产品编号: MS-T65161 纯度: 99.68% CAS No.: 3094177-94-0 分子式: C53H65N9O7 分子量: 940.14
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价

产品描述

U7D-1 是一种首创的、有效的和选择性的泛素特异性蛋白酶 7(USP7)PROTAC 降解剂,在 RS4;11 细胞中 DC50 为 33 nM,具有抗癌活性,并可诱导 Jeko-1 细胞凋亡(apoptosis)(粉色:USP7 配体(MS-C74307);蓝色:Cereblon 配体(MS-N78428);黑色:连接子)。

生物实验数据

生物活性 U7D-1 is a first-in-class, potent and selective ubiquitin-specific protease 7 (USP7) PROTAC degrader with a DC50 of 33 nM in RS4;11 cells, possesses anticancer activity, and induces apoptosis in Jeko-1 cells (pink: USP7 ligand (MS-C74307); blue: Cereblon ligand (MS-N78428); black: linker).
IC50 & Target

USP7

 

体外研究
(In Vitro)

U7D-1 (0-1 μM, 0-24 h) induced USP7 degradation in RS4;11 cell, reducing the USP7 protein level by 83.2% at 1 μM.
U7D-1 (0-20 μM, 3 days) shows anti-proliferative activity in p53 wild-type cell lines, and maintains potent cell growth inhibition in p53 mutant cancer cells.
U7D-1 (1 μM, 0-24 h) upregulates the level of p53 and p21 proteins in a time-dependent manner, and induces cleavage of caspase-3 in the Jeko-1 cell line in a time dependent manner.
U7D-1 (1 μM, 24 h) up-regulates the expression of apoptotic related genes and down-regulates the expression of E2F related genes in Jeko-1 cells.

Western Blot Analysis

Cell Line: RS4;11 cells
Concentration: 0, 5, 20, 50, 100, and 500 nM
Incubation Time: 24 h
Result: Induced USP7 degradation in RS4;11 cell in a dose dependent manner, with a DC50 (half-maximal degradation) value of 33 nM.

Cell Proliferation Assay

Cell Line: p53 wild-type cell lines (RS4;11, OCI-ly10, MV4;11, Reh and MOLT4 cell lines); p53 mutant cell lines (Jeko-1 cells, Mino, RPMI-8226, Jurkat, SU-DHL-6, CCRF-CEM)
Concentration: 0-20 μM
Incubation Time: 3 days
Result: Showed antiproliferative activity in p53 wild-type cell lines (RS4;11, OCI-ly10, MV4;11, Reh and MOLT4 cell lines), and p53 mutant cell lines (Jeko-1 cells, Mino, RPMI-8226, Jurkat, SU-DHL-6, CCRF-CEM), with IC50 values for 3 days of 79.4, 227.0, 830.3, 1367.2, 4948.0, 1034.9, 1175.3, 1860.6, 6077.6, 9078.0, and 10675.0, respectively. Had an antiproliferative activity with an IC50 value of 53.5 nM in Jeko-1 cells for 7 days but exhibited a 13-fold loss in antiproliferative activity with an IC50 value of 727 nM in Jeko-1 CRBN KO cells.

Western Blot Analysis

Cell Line: RS4;11 cells, Jeko-1 and Mino cell
Concentration: 1 μM
Incubation Time: 0, 2, 4, 6, 8, 10, 12, 20, 24, 36, 48, 60, and 72 h
Result: USP7 degradation in RS4;11 cells induced by U7D-1 started after 4 h of exposure and more effective degradation was observed after 8 h of exposure. Up-regulated the level of p53 and p21 proteins in RS4;11 cells in a time-dependent manner. Had no effect on the level of p53 protein in p53-mutant cell lines. Induced cleavage of caspase-3 in the Jeko-1 cell line in a time dependent manner.
性状 固体
颜色 White to light yellow

化学信息

分子量 940.14
分子式 C53H65N9O7
CAS No. 3094177-94-0

储存&溶解度

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 100 mg/mL (106.37 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM1.0637 mL5.3184 mL10.6367 mL26.5918 mL
5 mM0.2127 mL1.0637 mL2.1273 mL5.3184 mL
10 mM0.1064 mL0.5318 mL1.0637 mL2.6592 mL
15 mM0.0709 mL0.3546 mL0.7091 mL1.7728 mL
20 mM0.0532 mL0.2659 mL0.5318 mL1.3296 mL
25 mM0.0425 mL0.2127 mL0.4255 mL1.0637 mL
30 mM0.0355 mL0.1773 mL0.3546 mL0.8864 mL
40 mM0.0266 mL0.1330 mL0.2659 mL0.6648 mL
50 mM0.0213 mL0.1064 mL0.2127 mL0.5318 mL
60 mM0.0177 mL0.0886 mL0.1773 mL0.4432 mL
80 mM0.0133 mL0.0665 mL0.1330 mL0.3324 mL
100 mM0.0106 mL0.0532 mL0.1064 mL0.2659 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础